ash 2018: earlier smoldering myeloma treatment & the promise study
Published 5 years ago • 207 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
2:09
ash 2018: deter - dara rev dex for high-risk smoldering myeloma
-
58:44
treatments available for high risk smoldering myeloma patients
-
20:23
mcrt scottsdale 2018: smoldering myeloma, mgus and strategies for myeloma treatment
-
2:01
ash 2019: high-risk smoldering myeloma treatment research | dr. irene ghobrial
-
8:26
ash 2018: selinexor, daratumumab and dexamethasone for relapsed/refractory myeloma
-
2:55
ash 2019: the optimum trial | dr. martin kaiser
-
3:48
finding al amyloidosis early in mgus and smoldering myeloma patients with lambda features
-
3:22
genomic profiling in high-risk smoldering myeloma | benjamin diamond, md | ash 2023
-
9:41
mgus/smoldering myeloma pcrowd study by dr. irene ghobrial
-
1:28
ash 2018: using exercise (even resistance training) in multiple myeloma patients
-
2:52
how to join the mgus/smoldering myeloma pcrowd study
-
1:26
identifying high-risk smoldering myeloma & minimizing treatment-related toxicity
-
1:44
is there a clear definition for standard-risk smoldering myeloma?
-
21:10
smoldering multiple myeloma
-
1:47
the potential of early treatment of smm with immunotherapy
-
1:44
smoldering myeloma: the challenges of 'watch and wait' versus early intervention
-
1:03:53
healthtree podcast for multiple myeloma: elisabet manasanch, md, md anderson
-
1:02:49
a nationwide trial for smoldering myeloma patients
-
3:37
irene ghobrial: preventing progression from smoldering to symptomatic myeloma